Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors

Bone Marrow Transplantation
Gernot ReichGeorg Maschmeyer

Abstract

From November 1994 to May 1998, 117 patients (66 with solid tumor, 36 with lymphoma, 14 with multiple myeloma, one with acute leukemia) underwent 178 cycles of high-dose chemotherapy and autologous stem cell transplantation (ASCT) at our institution. We retrospectively analyzed the infectious complications that occurred after ASCT. Median duration of neutropenia (granulocyte count <0.5 x 10(9)/l ) was 8 days, the overall incidence of fever requiring antimicrobial treatment was 63%. 35.4% of patients had fever of unknown orign (FUO), whereas primary bacteremia occurred in 21.3%, pneumonia in 3.4% and severe skin infection in 1.1% of patients. Invasive fungal infections occurred in three, and enterocolitis in one patient. Infection was fatal in three patients (2.6%), in each case due to septic shock. The most frequently isolated pathogens were Gram-positive cocci. Median time to defervescence with antimicrobial therapy was 4 days (6 days in patients with bacteremia or other severe infection, and 3 days in patients with FUO). First-line antimicrobial therapy was successful in 65% of patients with FUO and 30.6% of patients with documented infections. With respect to the incidence, type and clinical course of infection, no significa...Continue Reading

References

Jan 1, 1991·Medical and Pediatric Oncology·T WatanabeA Yokobayashi
Jan 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L J AyashR Gonin
Jun 1, 1995·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D D'AntonioT Bonfini
May 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C GilbertW P Peters
Oct 6, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W T HughesL S Young

❮ Previous
Next ❯

Citations

May 23, 2006·Intensive Care Medicine·Elie Azoulay, Benoît Schlemmer
Dec 6, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B S SohnC Suh
Jun 7, 2005·Diagnostic Microbiology and Infectious Disease·Alfred Lennart BissingerHolger Hebart
Dec 3, 2005·Hematology·Steve ScaglionePatrick Stiff
Jul 16, 2013·BMC Infectious Diseases·Simone LaniniChristopher C Kibbler
Aug 27, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Liana Leite Duval FernandesMaria Cynésia Medeiros de Barros Torres
Jun 3, 2009·Expert Review of Anti-infective Therapy·Elio Castagnola, Maura Faraci
Mar 1, 2006·Expert Review of Anticancer Therapy·Morie A GertzShaji K Kumar
Aug 26, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Hani MawardiSook-Bin Woo
Jun 25, 2009·Seminars in Hematology·Marcio Nucci, Elias Anaissie
May 27, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Georg MaschmeyerGloria Mattiuzzi
May 17, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G MaschmeyerUNKNOWN Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology
Jul 16, 2005·Journal of Internal Medicine·M López DuplaJ Mensa
Jan 13, 2006·European Journal of Haematology·Pascale FrèreYves Beguin
Jan 3, 2013·Transplant Infectious Disease : an Official Journal of the Transplantation Society·S TaimurV Sanchorawala
Nov 22, 2013·Transplant Infectious Disease : an Official Journal of the Transplantation Society·A SrinivasanR T Hayden
Mar 17, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Javier de la RubiaMiguel A Sanz
Feb 22, 2012·São Paulo Medical Journal = Revista Paulista De Medicina·Kelli Borges SantosLuiz Cláudio Ribeiro
Jan 18, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M SandherrUNKNOWN Infectious Diseases Working Party, German Society for Hematology and Oncology
Jul 17, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shuling ZhangBeverly A Mock
Jul 22, 2019·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Brandon S WalkerKimberly E Hanson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.